- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.07. | First-in-class hay fever immunotherapy backed for NHS use | ||
| 21.07. | Survival data back Tagrisso's role in first-line lung cancer | ||
| 21.07. | Merck's SpringWorks takeover delivers a drug approval | ||
| 21.07. | Roche's COPD candidate fails a phase 3 readout | ||
| 21.07. | Sarepta resists as FDA seeks pause on Elevidys use | ||
| 18.07. | Third death reported with a Sarepta gene therapy | ||
| 18.07. | BMS, Pfizer take DTC route for blood thinner Eliquis | ||
| 18.07. | GSK's growth plans dented by Blenrep setback | ||
| 18.07. | UK plans to invest 'billions' in Essex biosecurity centre | ||
| 17.07. | Medical chatbot firm OpenEvidence raises $210m | ||
| 17.07. | NICE relents and backs Kisqali for wide use in breast cancer | ||
| 17.07. | EVERSANA unveils new AI-powered pharmacovigilance suite | ||
| 17.07. | Four AIs for spinal fractures can be used by NHS, says NICE | ||
| 17.07. | Bayer extends CEO contract amid 'signs of success' | ||
| 17.07. | UK plan to lead life sciences gets mixed response | ||
| 16.07. | NHS trust rolls out digital health tool for kidney disease | ||
| 16.07. | FDA fast-tracks Sanofi's gene therapy for eye disease GA | ||
| 16.07. | AstraZeneca sifts for efficacy crumbs in amyloidosis trial | ||
| 16.07. | MSD, AZ partner LaNova bought by Sino Biopharm for $951m | ||
| 16.07. | HHS layoffs are finalised as thousands of pink slips arrive | ||
| 15.07. | Hengrui to file obesity shot in China after phase 3 win | ||
| 15.07. | LEO bulks up with deal for Boehringer skin drug | ||
| 15.07. | Gilead's twice-yearly HIV PrEP set for wider rollout | ||
| 15.07. | UK Biobank charts success of NHS imaging project | ||
| 15.07. | New cystic fibrosis triple from Vertex backed for NHS use |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .